New York City pharmacies banned from selling cigarettesA bill signed by NYC Mayor Bill de Blasio in 2017 that prohibits New York City pharmacies from selling cigarettes and other tobacco products took effect Jan. 1. FDA: CBD still illegal in food, supplementsWith the Farm Bill signed, the Food and Drug Administration reiterated its authority to regulate products containing cannabis or cannabis-derived ingredients. 2018 policy in review: Pros, cons and promise ADVI’s Lindsay Bealor Greenleaf takes a look at the regulatory efforts that marked 2018 — and forecasts what 2019 may hold. FDA gives Celltrion, Teva green light for biosimilar Herceptin The Food and Drug Administration has approved Celltrion and Teva’s biosimilar to Herceptin, Herzuma (trastruzumab-pkrb). NACDS reacts to Texas Federal District Court’s ruling to strike down ACA NACDS vows additional advocacy efforts in light of Texas federal district court ruling to strike down the ACA. CRN: Farm Bill offers promise for hemp, lacks VMS SNAP measure Pleased that the Farm Bill includes the Hemp Farming Act, the Council for Responsible Nutrition noted its disappointment that it omits the SNAP Vitamin and Supplements Improvement Act. CRN applauds FDA's new dietary supplement working group A new Food and Drug Administration working group will re-examine policies for dietary supplements. FDA pulls generics labeling proposed rule The FDA has withdrawn a 2013 proposed rule that would have allowed generic drug makers to independently update drug labels. FDA issues new guidances to advance biosimilars The Food and Drug Administration said it expects to focus on preventing potentially anti-competitive practices for biosimilar drugs. FDA issues draft guidance to ensure safety of compounded drugs The FDA's revised draft guidance aims to protect patients from contaminated or substandard compounded drugs. First Previous 90 91 92 93 94 Next Last
